Rocuronium bromide and Rash erythematous - a phase IV clinical study of FDA data

Summary:

Rash erythematous is reported as a side effect among people who take Rocuronium bromide (rocuronium bromide), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Propofol, and have Anaesthesia.

The phase IV clinical study analyzes which people have Rash erythematous when taking Rocuronium bromide. It is created by eHealthMe based on reports of 5,609 people who have side effects when taking Rocuronium bromide from the FDA, and is updated regularly.

What is Rocuronium bromide?

Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.

What is Rash erythematous?

Rash erythematous (redness of the skin) is found to be associated with 1,809 drugs and 1,903 conditions by eHealthMe. Check the latest studies of Rash erythematous.

On Jul, 13, 2026

5,609 people reported to have side effects when taking Rocuronium bromide.
Among them, 22 people (0.39%) have Rash erythematous.

Could Rocuronium bromide cause Rash erythematous?

Among these 22 people:

How long have people been on Rocuronium bromide when they have Rash erythematous? *

What is the gender of people who have Rash erythematous when taking Rocuronium bromide? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Rash erythematous when taking Rocuronium bromide? *

What are other drugs people take besides Rocuronium bromide? *

What are other side effects people have besides Rash erythematous? *

Hypotension (abnormally low blood pressure): 11 people, 50.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 7 people, 31.82%
Dermatitis Exfoliative Generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface): 4 people, 18.18%
Eosinophilia (eosinophil count in the peripheral blood exceeds): 4 people, 18.18%
Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 18.18%
Oxygen Saturation Decreased: 3 people, 13.64%
Tongue Oedema (swelling of tongue): 3 people, 13.64%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 3 people, 13.64%
Skin Discoloration - Bluish (bluish colour of skin): 3 people, 13.64%
Rash Macular (small, flat red spots): 2 people, 9.09%

What are the existing conditions these people have? *

Anaesthesia: 6 people, 27.27%
Nausea And Vomiting: 3 people, 13.64%
Sensory Disturbance (sense disturbance): 1 person, 4.55%
General Anaesthesia: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Rocuronium bromide and have Rash erythematous?

- Check whether Rash erythematous is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rocuronium bromide:

Rocuronium bromide (5,615 reports)

Browse all side effects of Rocuronium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rash erythematous:

Rash erythematous (1,809 drugs)

Browse all the conditions that are associated with Rash erythematous:

Rash erythematous (1,903 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rocuronium bromide (the active ingredients of Rocuronium bromide) and Rocuronium bromide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.